These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Efficacy and safety of felbamate in children under 4 years of age: a retrospective chart review. Grosso S, Cordelli DM, Coppola G, Franzoni E, Verrotti A, Berardi R, Balestri P. Eur J Neurol; 2008 Sep; 15(9):940-6. PubMed ID: 18637038 [Abstract] [Full Text] [Related]
23. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). Felbamate Study Group in Lennox-Gastaut Syndrome. N Engl J Med; 1993 Jan 07; 328(1):29-33. PubMed ID: 8347179 [Abstract] [Full Text] [Related]
24. Effect of felbamate on the pharmacokinetics of lamotrigine. Colucci R, Glue P, Holt B, Banfield C, Reidenberg P, Meehan JW, Pai S, Nomeir A, Lim J, Lin CC, Affrime MB. J Clin Pharmacol; 1996 Jul 07; 36(7):634-8. PubMed ID: 8844446 [Abstract] [Full Text] [Related]
25. [Advantages and disadvantages of new antiepileptic drugs]. Herranz JL. Rev Neurol; 1996 Nov 07; 24(135):1426-34. PubMed ID: 8974750 [Abstract] [Full Text] [Related]
27. [Therapeutic drug monitoring of felbamate]. Tribut O, Bentué-Ferrer D, Verdier MC, le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Therapie; 2010 Nov 07; 65(1):35-8. PubMed ID: 20205993 [Abstract] [Full Text] [Related]
29. Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy. Ragueneau-Majlessi I, Levy RH, Brodie M, Smith D, Shah J, Grundy JS. Clin Pharmacokinet; 2005 Nov 07; 44(5):517-23. PubMed ID: 15871637 [Abstract] [Full Text] [Related]
31. [Felbamate: perspectives for new antiepileptic treatment]. Pérez-Miranda J, Aguirre J, Parrilla JL, Pérez Miranda M. Rev Neurol; 1995 Nov 07; 23(124):1220-5. PubMed ID: 8556622 [Abstract] [Full Text] [Related]
32. Single and multiple dose pharmacokinetics of felbamate in the elderly. Richens A, Banfield CR, Salfi M, Nomeir A, Lin CC, Jensen P, Affrime MB, Glue P. Br J Clin Pharmacol; 1997 Aug 07; 44(2):129-34. PubMed ID: 9278196 [Abstract] [Full Text] [Related]
34. Isobolographic and subthreshold analysis of interactions among felbamate and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice. Borowicz KK, Luszczki JJ, Czuczwar SJ. Epilepsia; 2004 Oct 07; 45(10):1176-83. PubMed ID: 15461671 [Abstract] [Full Text] [Related]
35. Felbamate as add-on therapy. Li LM, Nashef L, Moriarty J, Duncan JS, Sander JW. Eur Neurol; 1996 Oct 07; 36(3):146-8. PubMed ID: 8738944 [Abstract] [Full Text] [Related]
36. Drug concentrations in human brain tissue samples from epileptic patients treated with felbamate. Adusumalli VE, Wichmann JK, Kucharczyk N, Kamin M, Sofia RD, French J, Sperling M, Bourgeois B, Devinsky O, Dreifuss FE. Drug Metab Dispos; 1994 Oct 07; 22(1):168-70. PubMed ID: 8149879 [No Abstract] [Full Text] [Related]
37. Is there any future for felbamate treatment? Borowicz KK, Piskorska B, Kimber-Trojnar Z, Małek R, Sobieszek G, Czuczwar SJ. Pol J Pharmacol; 2004 Oct 07; 56(3):289-94. PubMed ID: 15215558 [Abstract] [Full Text] [Related]
38. Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience. Shah YD, Singh K, Friedman D, Devinsky O, Kothare SV. Epilepsy Behav; 2016 Mar 07; 56():50-3. PubMed ID: 26828692 [Abstract] [Full Text] [Related]